{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T23:03:53Z","timestamp":1768863833595,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jvascsurg.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jvs.2016.05.084","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T01:31:35Z","timestamp":1469842295000},"page":"1503-1514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Drug-eluting balloon angioplasty versus uncoated balloon angioplasty in patients with femoropopliteal arterial occlusive disease"],"prefix":"10.1016","volume":"64","author":[{"given":"Hidde","family":"Jongsma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost A.","family":"Bekken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul P.M.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hence J.","family":"Verhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bram","family":"Fioole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl S","key":"10.1016\/j.jvs.2016.05.084_bib1","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2016.05.084_bib2","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","volume":"32","author":"European Stroke","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2016.05.084_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00270-014-0955-5","article-title":"Outcomes of infrainguinal revascularizations with endovascular first strategy in critical limb ischemia","volume":"38","author":"Jens","year":"2015","journal-title":"Cardiovasc Intervent Radio"},{"key":"10.1016\/j.jvs.2016.05.084_bib4","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Adam","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2016.05.084_bib5","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ccd.21104","article-title":"Performance goals and end point assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease","volume":"69","author":"Rocha-Singh","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2016.05.084_bib6","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies","volume":"61","author":"Dake","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2016.05.084_bib7","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/ccd.22128","article-title":"Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions","volume":"74","author":"Dick","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2016.05.084_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468","article-title":"Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial","volume":"3","author":"Laird","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2016.05.084_bib9","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2016.05.084_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","article-title":"Prevalence and clinical impact of stent fractures after femoropopliteal stenting","volume":"45","author":"Scheinert","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2016.05.084_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9290(03)00259-8","article-title":"Flow-tissue interaction with compliance mismatch in a model stented artery","volume":"37","author":"Tortoriello","year":"2004","journal-title":"J\u00a0Biomech"},{"key":"10.1016\/j.jvs.2016.05.084_bib12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2016.05.084_bib13","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2016.05.084_bib14","unstructured":"Scheinert D. LEVANT I Trial 6-Month Results\u2014A Comparison of the MoxyTM Drug Coated Balloon Catheter vs Standard PTA for Femoropopliteal Disease. Transcatheter Cardiovascular Therapeutics Congress S, Washington, DC; 2010. Oral presentation."},{"key":"10.1016\/j.jvs.2016.05.084_bib15","unstructured":"Werk MAT, Meyer DR, Stiepani H, Schnorr B, Dietz U, Lopez H\u00e4nninen E. The PACIFIER trial. A randomized multicenter trial evalu- ating prevention of restenosis with paclitaxel-coated PTA balloon cath- eters in stenosis or occlusion of femoropopliteal arteries. Cardiovascular and Interventional Radiological Society of Europe Congress, September 2011, Munich; 2011. Oral presentation. Available at: http:\/\/www.esir.org\/cslide\/library\/esir\/mylibrary\/authors\/W\/M.+Werk. Accessed December 31,\u00a02011."},{"key":"10.1016\/j.jvs.2016.05.084_bib16","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCINTERVENTIONS.112.969972","article-title":"Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials","volume":"5","author":"Cassese","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2016.05.084_bib17","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jvs.2016.05.084_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2016.05.084_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2016.05.084_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1526602814564383","article-title":"Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial","volume":"22","author":"Scheinert","year":"2015","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2016.05.084_bib21","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jcin.2013.07.010","article-title":"Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery)","volume":"6","author":"Liistro","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2016.05.084_bib22","first-page":"207","article-title":"The \u201cDEBELLUM\u201d \u2014Lower limb multilevel treatment with drug eluting balloon\u2014randomized trial: 1-year results","volume":"55","author":"Fanelli","year":"2014","journal-title":"J\u00a0Cardiovasc Surg"},{"key":"10.1016\/j.jvs.2016.05.084_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1583\/JEVT-12-3926MR.1","article-title":"Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial","volume":"19","author":"Fanelli","year":"2012","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2016.05.084_bib24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2016.05.084_bib25","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2016.05.084_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2016.05.084_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2016.05.084_bib28","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2016.05.084_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2016.05.084_bib30","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0002-9149(97)89339-3","article-title":"Ultrastructural characteristics of human atherectomy tissue from coronary and lower extremity arterial stenoses","volume":"77","author":"Bauriedel","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvs.2016.05.084_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/13-4420R.1","article-title":"Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study","volume":"21","author":"Liistro","year":"2014","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2016.05.084_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10557-016-6658-1","article-title":"Paclitaxel-coated balloons: investigation of drug transfer in healthy and atherosclerotic arteries: first experimental results in rabbits at low inflation pressure","volume":"30","author":"Stolzenburg","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jvs.2016.05.084_bib33","unstructured":"Scheinert D. Drug-coated balloon treatment for patients with intermittent claudication: new insights from the IN.PACT Global Study long lesion (\u226515 cm) imaging cohort. Presented at: EuroPCR; May 19, 2015; Paris, France."},{"key":"10.1016\/j.jvs.2016.05.084_bib34","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jcin.2016.02.014","article-title":"1-year results of paclitaxel-coated balloons for long femoropopliteal artery disease: evidence from the SFA-long study","volume":"9","author":"Micari","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2016.05.084_bib35","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/ATVBAHA.107.144220","article-title":"Vascular responses to drug eluting stents: importance of delayed healing","volume":"27","author":"Finn","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvs.2016.05.084_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/eci.12407","article-title":"Local delivery of paclitaxel in the treatment of peripheral arterial disease","volume":"45","author":"Ng","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jvs.2016.05.084_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/RLI.0b013e31820577df","article-title":"Dose response to Paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model","volume":"46","author":"Kelsch","year":"2011","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jvs.2016.05.084_bib38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00392-009-0008-2","article-title":"Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model","volume":"98","author":"Cremers","year":"2009","journal-title":"Clin Res Cardiol"},{"issue":"Suppl K","key":"10.1016\/j.jvs.2016.05.084_bib39","doi-asserted-by":"crossref","first-page":"K66","DOI":"10.4244\/EIJV7SKA12","article-title":"Coronary bifurcation lesions treated with the drug-eluting balloon: a preliminary insight from the DEBIUT study","volume":"7","author":"Belkacemi","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jvs.2016.05.084_bib40","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ccd.22468","article-title":"Optimization of drug-eluting balloon use for safety and efficacy: evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries","volume":"76","author":"Posa","year":"2010","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521416304219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521416304219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T06:06:56Z","timestamp":1635746816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521416304219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0741521416304219"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2016.05.084","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-eluting balloon angioplasty versus uncoated balloon angioplasty in patients with femoropopliteal arterial occlusive disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2016.05.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}